Skip to main content
Loading market data...
ETF NYSE Arca USD

Invesco S&P 500 Equal Weight Health Care ETF RSPH

Issuer: Invesco SEC registrant: Invesco Exchange-Traded Fund Trust Equity · US
Last price 39.37 USD Change: Up +0.69 Percent change: Up +1.78%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.40%
Prospectus 28 Aug 2025
Net assets
$766.9M
As of 31 Jul 2026
Holdings
63
As of 31 Jul 2026
12-month distribution yield
0.57%
Quarterly
Asset class
Equity
From holdings

Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Invesco. Its category is Equity · US (equity). Its last price was US$39.37 on 20 Oct 2026. Its expense ratio is 0.4% a year, from its prospectus dated 28 Aug 2025. It reported net assets of US$766.87 million as of 31 Jul 2026. Its latest holdings report lists 63 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.22 a unit, a 12-month distribution yield of 0.57%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.40%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.40%
Prospectus date
28 Aug 2025
Filed with the SEC
27 Aug 2025

Size and reporting

Net assets
$766,866,028
Total assets
$784,427,005
Holdings as of
31 Jul 2026
Report made public
28 Sep 2026 (59 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 63 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.

RSPH top holdings as of 31 Jul 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 Bio-Techne Corp. US09073M1045 2.13% $16.3M Equity (common) United States USD
2 IQVIA Holdings Inc. US46266C1053 2.00% $15.3M Equity (common) United States USD
3 Baxter International Inc. US0718131099 1.99% $15.3M Equity (common) United States USD
4 Regeneron Pharmaceuticals, Inc. US75886F1075 1.96% $15.1M Equity (common) United States USD
5 Mettler-Toledo International Inc. US5926881054 1.94% $14.9M Equity (common) United States USD
6 Charles River Laboratories International, Inc. US1598641074 1.93% $14.8M Equity (common) United States USD
7 Veeva Systems Inc. Veeva Systems Inc., Class A US9224751084 1.93% $14.8M Equity (common) United States USD
8 DaVita Inc. US23918K1088 1.87% $14.4M Equity (common) United States USD
9 Moderna, Inc. US60770K1079 1.85% $14.1M Equity (common) United States USD
10 Thermo Fisher Scientific Inc. US8835561023 1.84% $14.1M Equity (common) United States USD
11 Abbott Laboratories US0028241000 1.83% $14.1M Equity (common) United States USD
12 Bristol-Myers Squibb Co. US1101221083 1.82% $13.9M Equity (common) United States USD
13 Universal Health Services, Inc. Universal Health Services, Inc., Class B US9139031002 1.80% $13.8M Equity (common) United States USD
14 Labcorp Holdings Inc. US5049221055 1.78% $13.7M Equity (common) United States USD
15 Quest Diagnostics Inc. US74834L1008 1.77% $13.6M Equity (common) United States USD
16 Amgen Inc. US0311621009 1.77% $13.5M Equity (common) United States USD
17 Incyte Corp. US45337C1027 1.76% $13.5M Equity (common) United States USD
18 Becton, Dickinson and Co. US0758871091 1.73% $13.3M Equity (common) United States USD
19 DexCom, Inc. US2521311074 1.73% $13.2M Equity (common) United States USD
20 AbbVie Inc. US00287Y1091 1.73% $13.2M Equity (common) United States USD
21 Viatris Inc. US92556V1061 1.72% $13.2M Equity (common) United States USD
22 Revvity, Inc. US7140461093 1.72% $13.2M Equity (common) United States USD
23 Cencora, Inc. US03073E1055 1.71% $13.1M Equity (common) United States USD
24 Steris PLC IE00BFY8C754 1.70% $13.0M Equity (common) Ireland USD
25 Insulet Corp. US45784P1012 1.70% $13.0M Equity (common) United States USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 99.90%
Short-term investment vehicles (cash funds) 2.30%

Country

Country by weight
CountryWeightBar
United States 98.85%
Ireland 3.35%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 102.20%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 85.94%
Industrials 10.38%
Technology 1.93%
Consumer Staples 1.65%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.2240
4 payments per unit
12-month yield
0.57%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
21 Sep 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.2240) ÷ latest price ($39.37) × 100 = 0.57%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (20 payments)
RSPH distributions per unit by ex-date
Ex-dateAmount per unit
21 Sep 2026$0.0520
22 Jun 2026$0.0630
23 Mar 2026$0.0560
22 Dec 2025$0.0530
22 Sep 2025$0.0600
23 Jun 2025$0.0550
24 Mar 2025$0.0550
23 Dec 2024$0.0570
23 Sep 2024$0.0550
24 Jun 2024$0.0510
18 Mar 2024$0.0460
18 Dec 2023$0.0500
18 Sep 2023$0.0480
20 Jun 2023$0.0511
20 Mar 2023$0.0485
19 Dec 2022$0.0456
19 Sep 2022$0.0391
21 Jun 2022$0.0460
21 Mar 2022$0.0534
20 Dec 2021$0.0573

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme